Using polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNF.

Pharmaceutical Research
James P BertramErin B Lavik

Abstract

Brain-derived neurotrophic factor (BDNF) plays an important role in neuroprotection and repair, but long-term delivery from polymer systems has been challenging. We investigated the role the chemistry of the polymer played in loading and delivery of BDNF via microspheres, which are suitable for minimally invasive administration. We synthesized polymers based on PLGA and PEG to determine what components augmented loading and delivery. We characterized microspheres fabricated from these polymers using a battery of tests, including sizing, in vitro release, and bioactivity of the BDNF using PC12 cells engineered to express the trkB receptor. We found that a triblock polymer of PLGA, PLL, and PEG led to the delivery of BDNF for periods of time greater than 60 days and that the BDNF delivered was bioactive. The microsphere size was amendable to injection via a 30 gauge needle, allowing minimally invasive delivery. PLGA-PLL-PEG leads to greater loading and longer-term delivery of BDNF than PLGA or a blend of the polymers. We hypothesize that the introduction of an amphiphilic PLGA-based polymer increases the interaction of the BDNF with the polymer and leads to release that more closely correlates with the degradation of the polymer.

References

Jul 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·L A Greene, A S Tischler
Oct 1, 1985·Analytical Biochemistry·P K SmithD C Klenk
Jan 1, 1996·Journal of Biomaterials Science. Polymer Edition·C E KrewsonW M Saltzman
Mar 6, 1998·Nature Biotechnology·S D Putney, P A Burke
Nov 5, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·J M PéanJ P Benoit
Mar 11, 2000·The European Journal of Neuroscience·C Vicario-AbejónR D McKay
Jan 6, 2001·Pharmaceutical Research·M van de WeertW Jiskoot
Jun 12, 2001·Current Opinion in Neurobiology·A Patapoutian, L F Reichardt
Nov 2, 2001·Nature Biotechnology·T P RichardsonD J Mooney
Jan 10, 2002·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·J ElisseeffR Langer
Mar 21, 2002·The Journal of Pharmacy and Pharmacology·Caroline PérezKai Griebenow
Feb 28, 2003·Journal of Neuroscience Research·Lisa N GillespiePhillip L Marzella
Jul 29, 2003·Journal of Pharmaceutical Sciences·Karen FuRobert Langer
Sep 19, 2003·Biochemical and Biophysical Research Communications·Takuya SuzukiMasayo Takahashi
Mar 12, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Ugo BilatiEric Doelker
Feb 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Millicent C FordErin B Lavik
May 17, 2006·Acta Biomaterialia·Dustin J MaxwellShelly E Sakiyama-Elbert
Sep 15, 2006·International Journal of Pharmaceutics·M Dolores BlancoJosé M Teijón
Dec 21, 2006·Journal of Pharmaceutical Sciences·M S WardM J Young
Jan 30, 2007·Bioconjugate Chemistry·Jyothi Devakumar, Vijayalakshmi Mookambeswaran
Feb 20, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Banu S Zolnik, Diane J Burgess
May 10, 2008·Journal of Biomedical Materials Research. Part a·Matthew D WoodShelly E Sakiyama-Elbert
Dec 5, 2008·Acta Biomaterialia·Noelle ComolliAnthony Lowman
Sep 10, 2009·Macromolecular Bioscience·Thimma Reddy Thatiparti, Horst A von Recum
Apr 1, 2008·Materials Science & Engineering. C, Materials for Biological Applications·Jessica O WinterJoseph F Rizzo

❮ Previous
Next ❯

Citations

Mar 13, 2014·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Joseph P Steiner, Avindra Nath
Jun 24, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xiang YiAlexander V Kabanov
Dec 22, 2015·International Journal of Pharmaceutics·Feng Wan, Mingshi Yang
Nov 3, 2015·International Journal of Pharmaceutics·Muhammad IqbalAbdelhamid Elaissari
Mar 19, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Javier Rodríguez VillanuevaManuel Guzmán Navarro
May 18, 2011·Biotechnology Progress·Mariana B Oliveira, João F Mano
Jul 28, 2015·Journal of Neuroscience Research·Johann K MikaEmmerich Bertagnolli
Jul 31, 2013·Drug Discovery Today·Angelina AngelovaSylviane Lesieur
Aug 21, 2013·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Tapan Kumar GiriDulal Krishna Tripathi
Oct 15, 2011·Biotechnology and Applied Biochemistry·Tina SedaghatiAlexander M Seifalian
Oct 19, 2013·Current Opinion in Neurology·Michel ModoLawrence R Wechsler
Feb 23, 2020·Journal of Tissue Engineering and Regenerative Medicine·Tanya SinghMaribel Vazquez
Nov 28, 2012·Advanced Healthcare Materials·Yit-Lung KhungSay Chye Joachim Loo
Aug 21, 2019·Frontiers in Neuroscience·Josh HoultonAndrew N Clarkson
Dec 5, 2020·Journal of Tissue Engineering and Regenerative Medicine·Richard N CliverMaribel Vazquez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.